🇲🇾 Country Profile

Malaysia

Expanding pharmaceutical supply to Malaysia

🇲🇾 $170M
All data from DGCIS India export records (fiscal year, April–March).
$170M
Scale
Malaysia's healthcare system receives $170M in Indian pharmaceutical products each year — affordable, quality medicine.
74%
Medicine
Primarily medicines (74%), supplemented by medicine ingredients and surgical & hospital supplies.
2.2×
Trajectory
India's pharmaceutical supply to Malaysia has grown 2.2× over the past decade — strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Malaysia — building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $125M (73.6%) Medicine Ingredients $29.3M (17.2%) Surgical & Hospital Supplies $8.1M (4.8%) Traditional & Herbal $4.9M (2.9%) Vaccines $2.5M (1.5%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Malaysia Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Malaysia: $800M across 29 filings (2011-2025).